Literature DB >> 19203719

Hematopoietic stem cell transplantation for bone marrow failure syndromes in children.

Kasiani C Myers1, Stella M Davies.   

Abstract

Bone marrow failure (BMF) syndromes include a broad group of diseases of varying etiologies, in which hematopoeisis is abnormal or completely arrested in one or more cell lines. BMF can be an acquired aplastic anemia (AA) or can be congenital, as part of such syndromes as Fanconi anemia (FA), Diamond Blackfan anemia, and Schwachman Diamond syndrome (SDS). In this review, we first address the evolution and current status of bone marrow transplantation (BMT) in the pediatric population in the most common form of BMF, acquired AA. We then discuss pediatric BMT in some of the more common inherited BMF syndromes, with emphasis on FA, in which experience is greatest. It is important to consider the possibility of a congenital etiology in every child (and adult) with marrow failure, because identification of an associated syndrome provides insight into the likely natural history of the disease, as well as prognosis, treatment options for the patient and family, and long-term sequelae both of the disease itself and its treatment.

Entities:  

Mesh:

Year:  2009        PMID: 19203719     DOI: 10.1016/j.bbmt.2008.11.037

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  26 in total

1.  Cyclophosphamide promotes engraftment of gene-modified cells in a mouse model of Fanconi anemia without causing cytogenetic abnormalities.

Authors:  Jennifer E Adair; Xin Zhao; Sylvia Chien; Min Fang; Martin E Wohlfahrt; Grant D Trobridge; Jason A Taylor; Brian C Beard; Hans-Peter Kiem; Pamela S Becker
Journal:  J Mol Med (Berl)       Date:  2012-06-03       Impact factor: 4.599

2.  Outcomes after related and unrelated umbilical cord blood transplantation for hereditary bone marrow failure syndromes other than Fanconi anemia.

Authors:  Renata Bizzetto; Carmen Bonfim; Vanderson Rocha; Gérard Socié; Franco Locatelli; Kawah Chan; Oscar Ramirez; Joel Stein; Samir Nabhan; Eliana Miranda; Jakob Passweg; Carmino Antonio de Souza; Eliane Gluckman
Journal:  Haematologica       Date:  2010-11-11       Impact factor: 9.941

Review 3.  Getting blood from bone: an emerging understanding of the role that osteoblasts play in regulating hematopoietic stem cells within their niche.

Authors:  Yusuke Shiozawa; Russell S Taichman
Journal:  Exp Hematol       Date:  2012-05-26       Impact factor: 3.084

Review 4.  New therapeutic approaches for protecting hematopoietic stem cells in aplastic anemia.

Authors:  Wendy Weston; Vineet Gupta; Rebecca Adkins; Roland Jurecic
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

5.  Stem cells in microfluidics.

Authors:  Huei-Wen Wu; Chun-Che Lin; Gwo-Bin Lee
Journal:  Biomicrofluidics       Date:  2011-03-30       Impact factor: 2.800

6.  Pain Management for Children during Bone Marrow and Stem Cell Transplantation.

Authors:  Kelly Vasquenza; Kathy Ruble; Allen Chen; Carol Billett; Lori Kozlowski; Sara Atwater; Sabine Kost-Byerly
Journal:  Pain Manag Nurs       Date:  2014-09-26       Impact factor: 1.929

Review 7.  Advances in unrelated and alternative donor hematopoietic cell transplantation for nonmalignant disorders.

Authors:  Shalini Shenoy; Jaap J Boelens
Journal:  Curr Opin Pediatr       Date:  2015-02       Impact factor: 2.856

Review 8.  Acquired aplastic anemia in children.

Authors:  Helge D Hartung; Timothy S Olson; Monica Bessler
Journal:  Pediatr Clin North Am       Date:  2013-10-16       Impact factor: 3.278

Review 9.  The Fanconi anemia pathway: repairing the link between DNA damage and squamous cell carcinoma.

Authors:  Lindsey E Romick-Rosendale; Vivian W Y Lui; Jennifer R Grandis; Susanne I Wells
Journal:  Mutat Res       Date:  2013-01-17       Impact factor: 2.433

10.  Musings on genome medicine: enzyme-replacement therapy of the lysosomal storage diseases.

Authors:  David G Nathan; Stuart H Orkin
Journal:  Genome Med       Date:  2009-12-09       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.